Enjuvia: profile and news

Barr Reports Second Quarter Fiscal 2006 GAAP Earnings of $0.88 Per ...  Feb 7, 2006
...our investment in marketing SEASONALE(R) through television and print advertising and began preparations for the anticipated launch of our Enjuvia(TM) hormone ... - MSN Money

Barr Reports Second Quarter Fiscal 2006 GAAP Earnings of $0.88 Per ...  Feb 7, 2006
...our investment in marketing SEASONALE(R) through television and print advertising and began preparations for the anticipated launch of our Enjuvia(TM) hormone ... - PR Newswire (press release),

UPDATE 1-Barr hormone ad was misleading, US FDA says  Jan 18, 2006
...years. The company plans to stop promoting Cenestin after the expected launch of another Barr estrogen therapy, Enjuvia, she said. ... - Reuters

Barr Reports GAAP Earnings of $2.03 Per Share for Fiscal 2005 and ...  Sep 8, 2005
...with our results for fiscal 2005 and are looking forward to the many opportunities in fiscal 2006, including the anticipated launch of our Enjuvia(R) hormone ... - PR Newswire (press release),

Barr Reports GAAP Earnings of $2.03 Per Share for Fiscal 2005 and ...  Sep 8, 2005
...our results for fiscal 2005 and are looking forward to the many opportunities in fiscal 2006, including the anticipated launch of our Enjuvia® hormone therapy ... - Yahoo! News (press release)